AAAAAA
Results: 1-25/32
Authors:
Abrams, P
Malone-Lee, J
Jacquetin, B
Wyndaele, JJ
Tammela, T
Jonas, U
Wein, A
Citation: P. Abrams et al., Twelve-month treatment of overactive bladder - Efficacy and tolerability of tolterodine, DRUG AGING, 18(7), 2001, pp. 551-560
Authors:
Hanke, B
Riedel, C
Lampert, S
Happich, K
Martus, P
Parsch, H
Himmler, B
Hohenberger, W
Hahn, EG
Wein, A
Citation: B. Hanke et al., CEA and CA 19-9 measurement as a monitoring parameter in metastatic colorectal cancer (CRC) under palliative first-line chemotherapy with weekly 24-hour infusion of high-dose 5-fluorouracil (5-FU) and folinic acid (FA), ANN ONCOL, 12(2), 2001, pp. 221-226
Authors:
Bittorf, B
Kessler, H
Merkel, S
Bruckl, W
Wein, A
Ballhausen, WG
Hohenberger, W
Gunther, K
Citation: B. Bittorf et al., Multiple primary malignancies: An epidemiological and pedigree analysis of57 patients with at least three tumours, EUR J SUR O, 27(3), 2001, pp. 302-313
Authors:
Andersson, KE
Chapple, C
Wein, A
Citation: Ke. Andersson et al., The basis for drug treatment of the overactive bladder, WORLD J URO, 19(5), 2001, pp. 294-298
Authors:
Appell, RA
Abrams, P
Drutz, HP
Van Kerrebroeck, PEVA
Millard, R
Wein, A
Citation: Ra. Appell et al., Treatment of overactive bladder: long-term tolerability and efficacy of tolterodine, WORLD J URO, 19(2), 2001, pp. 141-147
Authors:
Hartung, G
Hofheinz, RD
Wein, A
Riedel, C
Rost, A
Fritze, D
Kreuser, ED
Drees, M
Kuhnel, J
Hehlmann, R
Queisser, W
Citation: G. Hartung et al., Phase II study of a weekly 24-hour infusion with 5-fluorouracil and simultaneous sodium-folinic acid in the first-line treatment of metastatic colorectal cancer, ONKOLOGIE, 24(5), 2001, pp. 457-462
Authors:
Ricci, JA
Baggish, JS
Hunt, TL
Stewart, WF
Wein, A
Herzog, AR
Diokno, AC
Citation: Ja. Ricci et al., Coping strategies and health care-seeking behavior in a US national sampleof adults with symptoms suggestive of overactive bladder, CLIN THER, 23(8), 2001, pp. 1245-1259
Authors:
D'Amico, AV
Whittington, R
Malkowicz, SB
Renshaw, AA
Tomaszewski, JE
Bentley, C
Schultz, D
Rocha, S
Wein, A
Richie, JP
Citation: Av. D'Amico et al., Estimating the impact on prostate cancer mortality of incorporating prostate-specific antigen testing into screening, UROLOGY, 58(3), 2001, pp. 406-410
Authors:
Liberman, JN
Hunt, TL
Stewart, WF
Wein, A
Zhou, ZY
Herzog, AR
Lipton, RB
Diokno, AC
Citation: Jn. Liberman et al., Health-related quality of life among adults with symptoms of overactive bladder: Results from a US community-based survey, UROLOGY, 57(6), 2001, pp. 1044-1050
Authors:
Wein, A
Riedel, C
Bruckl, W
Kastl, S
Reingruber, B
Hohenberger, W
Hahn, EG
Citation: A. Wein et al., Weekly 24-h infusion of high-dose 5-Fluorouracil (5-FU) with folinic acid (FA) in adjuvant therapy of colon canter, Z GASTROENT, 39(2), 2001, pp. 153-156
Authors:
Rackley, R
Wein, A
Nelson, D
Citation: R. Rackley et al., Medical treatment of overactive bladder, MAYO CLIN P, 76(11), 2001, pp. 1179-1179
Authors:
D'Amico, AV
Whittington, R
Malkowicz, SB
Weinstein, M
Tomaszewski, JE
Schultz, D
Rhude, M
Rocha, S
Wein, A
Richie, JP
Citation: Av. D'Amico et al., Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen era, J UROL, 166(6), 2001, pp. 2185-2188
Authors:
Ott, R
Wein, A
Hohenberger, W
Citation: R. Ott et al., Liver metastases - primary or multimodal therapy?, CHIRURG, 72(8), 2001, pp. 887-897
Authors:
Merkel, S
Wein, A
Gunther, K
Papadopoulos, T
Hohenberger, W
Hermanek, P
Citation: S. Merkel et al., High-risk groups of patients with stage II colon carcinoma, CANCER, 92(6), 2001, pp. 1435-1443
Authors:
Wein, A
Riedel, C
Hanke, B
Lampert, S
Bruckl, W
Reingruber, B
Hohenberger, W
Hahn, EG
Citation: A. Wein et al., Improvements in the palliative treatment of colorectal carcinoma, DEUT MED WO, 125(5), 2000, pp. 121-125
Authors:
Bruckl, WM
Wein, A
Riedel, C
Wiest, GH
Hohenberger, W
Hahn, EG
Citation: Wm. Bruckl et al., Retroperitoneal desmoid tumour with renal failure in a patient with familial adenomatous polyposis, DEUT MED WO, 125(4), 2000, pp. 81-84
Authors:
D'Amico, AV
Whittington, R
Malkowicz, SB
Schultz, D
Silver, B
Henry, L
Hurwitz, M
Kaplan, I
Beard, CJ
Tomaszewski, JE
Renshaw, AA
Wein, A
Richie, JP
Citation: Av. D'Amico et al., Investigating the clinical utility of the percent of positive prostate biopsies in predicting PSA outcome following local therapy for patients with clinically localized prostate cancer, PROSTATE C, 3(4), 2000, pp. 259-264
Authors:
Chancellor, M
Freedman, S
Mitcheson, HD
Antoci, J
Primus, G
Wein, A
Citation: M. Chancellor et al., Tolterodine, an effective and well tolerated treatment for urge incontinence and other overactive bladder symptoms, CLIN DRUG I, 19(2), 2000, pp. 83-91
Authors:
D'Amico, AV
Whittington, R
Malkowicz, SB
Schultz, D
Silver, B
Henry, L
Hurwitz, M
Kaplan, I
Beard, CJ
Tomaszewski, JE
Renshaw, AA
Wein, A
Richie, JP
Citation: Av. D'Amico et al., Clinical utility of percent-positive prostate biopsies in. predicting biochemical outcome after radical prostatectomy or external-beam radiation therapy for patients with clinically localized prostate cancer, MOL UROL, 4(3), 2000, pp. 171-175
Authors:
Abrams, P
Wein, A
Citation: P. Abrams et A. Wein, Recent advances - Urology, BR MED J, 321(7273), 2000, pp. 1393-1396
Authors:
Wein, A
Hahn, EG
Merkel, S
Hohenberger, W
Citation: A. Wein et al., Adjuvant chemotherapy for stage II (Dukes' B) colon cancer: too early for routine use, EUR J SUR O, 26(8), 2000, pp. 730-732
Authors:
D'Amico, AV
Whittington, R
Malkowicz, SB
Schultz, D
Fondurulia, J
Chen, MH
Tomaszewski, JE
Renshaw, AA
Wein, A
Richie, JP
Citation: Av. D'Amico et al., Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer, J CL ONCOL, 18(6), 2000, pp. 1164-1172
Authors:
D'Amico, AV
Whittington, R
Malkowicz, SB
Wu, YH
Chen, MH
Hurwitz, M
Kantoff, PW
Tomaszewski, JE
Renshaw, AA
Wein, A
Richie, JP
Citation: Av. D'Amico et al., Utilizing predictions of early prostate-specific antigen failure to optimize patient selection for adjuvant systemic therapy trials, J CL ONCOL, 18(18), 2000, pp. 3240-3246
Authors:
Brueckl, WM
Limmert, T
Brabletz, T
Guenther, K
Jung, A
Hermann, K
Wiest, GH
Kirchner, T
Hohenberger, W
Hahn, EG
Wein, A
Citation: Wm. Brueckl et al., Mismatch repair deficiency in sporadic synchronous colorectal cancer, ANTICANC R, 20(6C), 2000, pp. 4727-4732
Authors:
Brueckl, WM
Jung, A
Wein, A
Brabletz, T
Guenther, K
Nusko, G
Hahn, EG
Citation: Wm. Brueckl et al., Microsatellite instability in colorectal adenomas: relevance and clinical importance, INT J COL R, 15(4), 2000, pp. 189-196